Milbemycin Oxime/Spinosad

62 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Milbemycin Oxime/Spinosad

Administration Routes

Oral

Species Affected

Dog 62

Most Affected Breeds

Retriever - Labrador 13

Retriever - Golden 5

Shepherd Dog - German 4

Crossbred Canine/dog 3

Shih Tzu 3

Shepherd Dog - Australian 2

Siberian Husky 2

Greyhound 2

Dachshund (unspecified) 2

Terrier - Cairn 2

Most Reported Reactions

INEFFECTIVE, HEARTWORM LARVAE 34

INEFFECTIVE, ASCARIDS NOS 4

Lack of efficacy - NOS 3

Lack of efficacy (endoparasite) - heartworm 3

Lack of efficacy (endoparasite) - hookworm 2

Seizure NOS 2

Underdose 2

Diarrhoea 2

Vomiting 2

Gingival hyperplasia 2

Lack of efficacy (endoparasite) - tapeworm 2

Emesis 2

Outcome Breakdown

Ongoing

32 (51.6%)

Recovered/Normal

15 (24.2%)

Outcome Unknown

14 (22.6%)

Recovered with Sequela

1 (1.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.